An evidence-based perspective to the medical treatment of male infertility: A short review

Urologia Internationalis

Volumn 82, Issue 2, 2009, Pages 125-129

  Ghanem, Hussein ^a   Shamloul, Rany ^a,b  

^a CAIRO UNIVERSITY   (Egypt)

^b QUEEN S UNIVERSITY   (Canada)

Author keywords

Evidence based medicine; Follicle stimulating hormone; Male infertility

Indexed keywords

ACETYLCARNITINE; ALPHA TOCOPHEROL; ASTAXANTHIN; CARNITINE; CLOMIFENE CITRATE; FOLIC ACID; FOLLITROPIN; GLUTATHIONE; GONADOTROPIN; LEPIDIUM MEYENII EXTRACT; PINUS MARITIMIA EXTRACT; PLANT EXTRACT; TAMOXIFEN; TAMOXIFEN CITRATE; TESTOSTERONE ENANTATE; TESTOSTERONE PHENYLPROPIONATE; TESTOSTERONE UNDECANOATE; UNCLASSIFIED DRUG; ZINC;

ANDROGEN THERAPY; ASTHENOSPERMIA; AZOOSPERMIA; CLINICAL TRIAL; COST BENEFIT ANALYSIS; DECISION MAKING; DIET SUPPLEMENTATION; DRUG DOSE TITRATION; ETHICS; EVIDENCE BASED MEDICINE; HUMAN; INTRACYTOPLASMIC SPERM INJECTION; MALE INFERTILITY; META ANALYSIS; MONOTHERAPY; OLIGOSPERMIA; PATIENT COUNSELING; PATIENT SAFETY; PHYSICIAN; PREGNANCY RATE; PRIORITY JOURNAL; REVIEW; SPERM; SPERMATOGENESIS; SPERMATOZOON DENSITY; SPERMATOZOON MOTILITY; SYSTEMATIC REVIEW;

ANDROGENS; ANTIOXIDANTS; CLINICAL TRIALS AS TOPIC; DIETARY SUPPLEMENTS; DRUG THERAPY, COMBINATION; ESTROGEN RECEPTOR MODULATORS; EVIDENCE-BASED MEDICINE; FEMALE; FERTILITY AGENTS, MALE; GONADOTROPINS; HUMANS; INFERTILITY, MALE; MALE; PATIENT RIGHTS; PREGNANCY; PREGNANCY RATE; RESEARCH DESIGN; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 63449121943     PISSN: 00421138     EISSN: None     Source Type: Journal    
DOI: 10.1159/000200785     Document Type: Review

References (30)

1. Backett DL, Rosenberg WM, Gray JA, Haynes RB, Richardson WS: Evidence-based medicine: what it is and what it isn't. Clin Orthop Relat Res 2007; 455: 3-5.
2. Attia AM, Al-Inany HG, Proctor ML: Gonadotrophins for idiopathic male factor subfertility. Cochrane Database Syst Rev 2006;1: CD005071.
3. Attia AM, Al-Inany HG, Proctor ML: Gonadotrophins for idiopathic male factor subfertility (update). Cochrane Database Syst Rev 2007;4:CD005071.
4. Kamischke A, Nieschlag E: Analysis of medical treatment of male infertility. Hum Reprod 1999; 14: 1-23.
5. Matorras R, Perez C, Corcostegui B, Pijoan JI,Ramon O, Delgado P, Rodriguez-Escudero FJ: Treatment of the male with follicle-stimulating hormone in intrauterine insemination with husband's spermatozoa: a randomized study. Hum Reprod 1997; 12: 24-28.
6. Comhaire F, Mahmoud A: The First World Congress on Controversies in Obstetrics, Gynecology and Infertility, Prague, 1999.
7. Gerris J, Comhaire F, Hellemans P, Peeters K, Schoonajs F: Placebo-controlled trial of highdose mestrolone treatment of idiopathic male infertility. Fertil Steril 1991; 55: 603-607.
8. Comhaire F: Treatment of idiopathic testicular failure with high-dose testosterone undecanoate: a double-blind pilot study. Fertil Steril 1990; 54: 689-693.
9. Comhaire F, Mahmoud A: Hormonal treatment of infertility; in Schill WB, Comhaire F, Hargreave T (eds): Andrology for the Clinician. Berlin, Springer, 1996, pp 516-519.
10. Vandekerckhove P, Lilford R, Vail A, Hughes E: Clomiphene or tamoxifen for idiopathic oligo/asthenospermia. Cochrane Database Syst Rev 2007;4:CD000151. (This paper has been withdrawn from the Cochrane library as it has not been updated since 1996.)
11. D ohle GR, Jungwirth A, Colpi G, Giwercman A, Diemer T, Hargreave TB: European Association of Urology Guidelines for Male Infertility. http://www.uroweb.org/file admin/user-upload/Guidelines/13%20Male%20Infertility. pdf (accessed Dec 11, 2007).
12. Hussein A, Ozgok Y, Ross C, Niederberger L: Clomiphene administration for cases of non-obstructive azoospermia: a multicenter study. J Androl 2005; 26: 787-791.
13. Comhaire FH, El Garem Y, Mahmoud A, Eertmans F, Schoonjans F: Combined conventional/antioxidant Astaxanthin treatment for male infertility: a double-blind, randomized trial. Asian J Androl 2005; 7: 257-262.
14. Adamopoulos DA, Pappa A, Billa E, Nicopoulou S, Koukkou E, Michopoulos J: Effectiveness of combined tamoxifen citrate and testosterone undecanoate treatment inmen with idiopathic oligozoospermia. Fertil Steril 2003; 80: 914-920.
15. Sharma RK, Agarwal A: Role of reactive oxygen species in male infertility. Urology 1996; 48: 835-850.
16. Raijmakers MT, Roelofs HM, Steegers EA, Steegers-Theunissen RRP, Mulder TP, Knapen MF, et al: Glutathione and glutathione S-transferases A1-1 and P1-1 in seminal plasma may play a role in protecting against oxidative damage to spermatozoa. Fertil Steril 2003; 79: 169-172.
17. Ochsendorf FR, Buhl R, Bastlein A, Beschmann H: Glutathione in spermatozoa and seminal plasma of infertile men. Hum Reprod 1998; 13: 353-359.
18. Lenzi A, Lombardo F, Gandini L, Culasso F, Dondero F: Glutathione therapy for male infertility. Arch Androl 1992; 29: 65-68.
19. Therond P, Auger J, Legrand A, Jouannet P: Alpha-tocopherol in human spermatozoa and seminal plasma: relationships with motility, antioxidant enzymes and leukocytes. Mol Hum Reprod 1996; 62: 739-744.
20. Keskes-Ammar L, Feki-Chakroun N, Rebai T, Sahnoun Z, Ghozzi H, Hammami S, et al: Sperm oxidative stress and the effect of an oral vitamin E and selenium supplement on semen quality in infertile men. Arch Androl 2003; 49: 83-94.
21. Kessopoulou E, Powers HJ, Sharma KK, Pearson MJ, Russell JM, Cooke ID, et al: A double-blind, randomized, placebo crossover controlled trial using the antioxidant vitamin E to treat reactive oxygen species associated male infertility. Fertil Steril 1995; 64: 825-831.
22. Rolf C, Cooper TG, Yeung CH, Nieschlag E: Antioxidant treatment of patients with asthenozoospermia or moderate oligoasthenozoospermia with high-dose vitamin C and vitamin E: a randomized, placebo-controlled, double-blind study. Hum Reprod 1999; 14: 1028-1033.
23. Kumar R, Gautam G, Gupta NP: Drug therapy for idiopathic male infertility: rationale versus evidence. J Urol 2006; 176: 1307-1312.
24. Lenzi A, Sgro P, Salacone P, Paoli D, Gilio B, Lombardo F, Santulli M, Agarwal A, Gandini L: A placebo-controlled double-blind randomized trial of the use of combined L - carnitine and L -acetylcarnitine treatment in men with asthenozoospermia. Fertil Steril 2004; 81: 1578-1584.
25. Balercia G, Regoli F, Armeni T, Koverech A, Mantero F, Boscaro M: Placebo-controlled, double-blind, randomized trial on the use of L -carnitine, L -acetylcarnitine, or combined L -carnitine and L -acetylcarnitine in men with idiopathic asthenozoospermia. Fertil Steril 2005; 84: 662-671.
26. Wong WY, Merkus HM, Thomas CM, Menkveld R, Zielhuis GA, Steegers-Theunissen RP: Effects of folic acid and zinc sulfate on male factor subfertility: a doubleblind, randomized, placebo-controlled trial. Fertil Steril 2002; 77: 491-498
27. Roseff S, Gulati R: Improvement of sperm quality by Pycnogenol. Eur Bull Drug Res 1999; 7: 33-36.
28. 28 Gonzales G, Ruiz A, Gonzales C, Villegas L, Cordova A: Effect of Lepidium meyneii (Maca) roots on spermatogenesis of male rats. Asian J Androl 2001; 3: 231-233.
29. Gonzales G, Cordova A, Gonzales C, Chung A, Vega K, Villena A: Lepidium meyenii (Maca) improved semen parameters in adult men. Asian J Androl 2001; 3: 301-303.
30. Buvat J, Buvat-Herbaut M, Marcolin G, Ardaens- Boulier K: Antiestrogens as treatment of female and male infertilities. Horm Res 1987; 28: 219-229.